Address: vul. Verkhniy Val, 4-B, office 219, Kyiv 04071, Ukraine
Tel: +380 (44) 493 91 30
The Association of Pharmaceutical Research and Development (APRaD) has been formed by 14 world leading pharmaceutical companies active in the research and development of new medicines that improve health and quality of life, with a presence in Ukraine.
The pharmaceutical industry, represented by APRaD, is committed to the research and development, quality manufacturing and distribution of innovative medicines that save lives, reduce overall health care costs and improve the quality of life of people. As a non-for-profit and non-governmental organization, APRaD gives much emphasis to co-operation with Ukrainian authorities, and other international organizations concerned with health and pharmaceutical industry-related issues.
The Association’s objectives are to become a recognized voice of the research-based pharmaceutical industry operating in Ukraine, to promote value of innovations, to conduct effective advocacy for public policies that improve access to quality medicines in Ukraine, and to be effective strategic partner to the Government of Ukraine.
APRaD Strategic priorities:
The Association focuses on four major areas: Access to Medicines and Reimbursement, Ethics, Partnership, and Intellectual Property Rights. Specifically, APRaD:
• Builds awareness about the R&D Pharmaceutical industry and original medicines;
• Strives to resolve Intellectual Property Rights and Data Protection issues
• Is the advocate for a better access to quality medicines and establishment of reimbursement system;
• Promotes and encourage ethical business principles and practices among its members and the pharmaceutical industry in general;
• Develops effective partnership with Government stakeholders as well as represent the interests of the pharmaceutical industry before all relevant authorities;
• Establishes appropriate links with international pharmaceutical associations;
The activities of the Association are not intended to generate profits. The Association has no intention whatsoever to create or promote cartels or gentlemen’s agreements and will put in place active measures to ensure such arrangements do not arise. The Association does not engage in trade, commercial transactions or political activities.
Our Strategic Working Groups:
To reach its objectives, APRaD functions through five Strategic Working Groups (SWGs): Access to Medicines and Reimbursement, Ethics, Intellectual Property Rights, Partnership, and Human Resource. Strategic Working Groups are forums for discussing issues, developing common opinions and positions, and acting respectively.
Dr. Volodymyr Redko, executive director of Ukraine’s Association of Pharmaceutical Research and Development (APRaD), which gathers together 15 international R&D-driven companies, provides insights into the perspective of international innovators vis-à-vis…
What was the vision behind the creation of APRaD back in 2007 and what was lacking in the market at that time that called for such an association? APRaD originated…
Petro Bagriy, president of the Association of Drug Manufacturers of Ukraine (AMMU), which gathers seven of the leading Ukrainian pharmaceutical companies, provides insights into the internal workings of the association…
Robert Chagalian, country manager of Siemens Healthineers Ukraine, provides a fascinating insight into the 165-year long presence of Siemens on the Ukrainian market, whilst highlighting the strong commitment of the…
Aleksandr Iavorskyi, founder and president of Biocon, Ukraine’s leading third-party logistics (3PL) company in the pharmaceutical and healthcare areas, provides insights into Biocon’s impressive development and unique partnership approach as…
Victoria Bandyk, chief operating officer of the Bioscience Group, provides insights into the unique added value and the international development of this comprehensive group of companies, which aims to support…
Roman Gladkyi, general manager of Ferring Ukraine, describes the current opportunities and areas for improvement he identifies within Ukraine’s pharmaceutical market and the country’s evolving heath system, with a special…
Evgeniy Gaydukov, Country Director of AstraZeneca Ukraine, provides insights into the remarkable growth that the science-led, innovative company has been experiencing in Ukraine despite the unstable economic situation in the…
Anatoliy Novyk, founder and president of SMC Ecopharm, the only Ukrainian pharmaceutical company to be exclusively focused on its own original drug development, provides insights into Ecopharm’s promising expansion strategy,…
Filya Zhebrovska, chairman of the supervisory board of Farmak and the company’s general director between 1995 and 2017, provides insights into the strategy she has followed to establish Farmak as…
Taras Velgosh, Adamed’s country manager in Ukraine, provides insights into the great results accomplished by the Ukrainian affiliate of this leading Polish pharmaceutical company despite the deep crisis that has…
Liana Maksyoutova, country manager of Polpharma Ukraine, provides insights into the impressive transformation of the Ukrainian affiliate that she has fostered since inheriting its reins in 2012 and how she…
Anatoliy Reder, founder and general director of InterChem, provides insights into the heightened international ambitions of this leading, science-based Ukrainian pharmaceutical company, which plans to leverage its unique R&D and…
Natalia Zago, managing director of Takeda Ukraine, one of the leading international companies operating in the country, provides insights into her main priorities to drive the growth of the company…
See our Cookie Privacy Policy Here
